Live

Xtandi

2 articles

Castration-Sensitive Prostate Cancer Market to Double to $11.75B by 2036

GlobeNewswire Inc.

GlobeNewswire Inc.·Apr 13·Researchandmarkets.Com

Castration-Sensitive Prostate Cancer Market to Double to $11.75B by 2036

CSPC market projected to surge from $5.14B (2025) to $11.75B (2036), driven by aging populations, new drug approvals, and emerging therapies.

JNJMRKPFENVSAZN+2Xtandicastration-sensitive prostate cancer

Pfizer's Dual Cancer Wins Boost Stock as Prostate, Breast Trials Succeed

Benzinga

Benzinga·Mar 19·Vandana Singh

Pfizer's Dual Cancer Wins Boost Stock as Prostate, Breast Trials Succeed

Pfizer shares rise on Phase 3 prostate cancer trial win and Phase 2 breast cancer success, validating its oncology pipeline and signaling near-term regulatory catalysts.

PFEbreast cancerPhase 3 trial